- Home
- OSCR vs LNTH Comparison
OSCR vs LNTH Comparison
Compare OSCR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSCR | LNTH |
|---|---|---|
| Founded | 2012 | 1956 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OSCR | LNTH |
|---|---|---|
| Price | $13.42 | $71.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $17.00 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 9.1M | 729.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $37.57 | N/A |
| Revenue Next Year | $14.77 | $0.46 |
| P/E Ratio | ★ N/A | $29.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.20 | $47.25 |
| 52 Week High | $23.80 | $111.29 |
Technical Indicators
Market Signals| Indicator | OSCR | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 40.52 | 71.31 |
| Support Level | $11.85 | $64.52 |
| Resistance Level | $14.57 | $68.70 |
| Average True Range (ATR) | 0.81 | 2.30 |
| MACD | 0.00 | 0.38 |
| Stochastic Oscillator | 47.33 | 97.00 |
Price Performance
Historical ComparisonAbout OSCR Oscar Health Inc.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.